Form C - Offering Statement:
SEC Accession No. 0002085093-25-000001
Filing Date
2025-11-05
Accepted
2025-11-05 12:44:40
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9164
2 CUREVALUE curevalue.pdf EX-99 43118598
  Complete submission text file 0002085093-25-000001.txt   59401967
Mailing Address 1207 DELAWARE AVE #826 826 WILMINGTON DE 19806
Business Address 1207 DELAWARE AVE #826 826 WILMINGTON DE 19806 17328608394
CureValue, Inc. (Filer) CIK: 0002085093 (see all company filings)

EIN.: 333746905 | State of Incorp.: DE | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-36540 | Film No.: 251452992